Urinary incontinence: Pathology review

Last updated: September 03, 2022

Urinary incontinence: Pathology review

Pharmacology

Pharmacology

Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Antimetabolites: Sulfonamides and trimethoprim
Herpesvirus medications
Neuraminidase inhibitors
Hepatitis medications
Nucleoside reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Protease inhibitors
Integrase and entry inhibitors
Anthelmintic medications
Anti-mite and louse medications
Antimalarials
Azoles
Echinocandins
Miscellaneous antifungal medications
Antituberculosis medications
Anaphylaxis
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
Loop diuretics
Osmotic diuretics
Adrenergic antagonists: Alpha blockers
ACE inhibitors, ARBs and direct renin inhibitors
cGMP mediated smooth muscle vasodilators
Positive inotropic medications
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Thrombolytics
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Antiplatelet medications
Mineralocorticoids and mineralocorticoid antagonists
Acid reducing medications
Glucocorticoids
Laxatives and cathartics
Medication-induced constipation: Clinical sciences
Inflammatory bowel disease: Pathology review
Pulmonary corticosteroids and mast cell inhibitors
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Approach to a cough (subacute and chronic): Clinical sciences
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Obesity and metabolic syndrome: Clinical sciences
Insulins
Osteoporosis medications
Hyperthyroidism medications
Hypothyroidism medications
Non-corticosteroid immunosuppressants and immunotherapies
Estrogens and antiestrogens
Androgens and antiandrogens
Opioid agonists, mixed agonist-antagonists and partial agonists
Non-steroidal anti-inflammatory drugs
Seizures and epilepsy
Local anesthetics
General anesthetics
Anticonvulsants and anxiolytics: Benzodiazepines
Anticonvulsants and anxiolytics: Barbiturates
Selective serotonin reuptake inhibitors
Atypical antidepressants
Tricyclic antidepressants
Lithium
Typical antipsychotics
Atypical antipsychotics
Anti-parkinson medications
Alzheimer disease: Clinical sciences
Allergic rhinitis: Clinical sciences
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Urinary incontinence: Pathology review
PDE5 inhibitors

Transcript

Watch video only

In the Urology ward, two people are coming in. The first is Oleg, a 70 year old man who says that he frequently has to use the bathroom and also complains of a weak urinary stream. The second is Samantha, a 55 year old woman who says that she “pees” a little when she laughs. Samantha also has 2 children and both were born by vaginal delivery. Now, both these individuals seem to have urinary incontinence.

Urinary incontinence is a problem where the process of urination happens involuntarily, meaning that a person might urinate without intending to. This is particularly problematic because it affects a person’s personal hygiene as well as their social life in a way that can be very limiting.

Let’s talk about physiology real quick. Okay, so as urine flows from the kidneys into the bladder, the bladder starts to fill. Lining the bladder is a layer of transitional epithelium containing “umbrella cells”. These cells physically stretch out as the bladder fills, just like an umbrella opening up in slow-motion. This expansion is further aided by the relaxation of the muscular layer within the bladder’s walls, called the detrusor muscle. At some point, the bladder fills up with urine that will eventually exit the body through the urethra.

Now, the urethra is wrapped up in some muscles that can prevent urine from leaking out. The first one is the internal sphincter muscle, which is made of smooth muscle and is under involuntary control and typically opens up when the bladder is about half full. The second one is the external sphincter muscle, and it’s made of skeletal muscle and is under voluntary control. This is the reason that it’s possible to stop urine mid-stream by tightening up that muscle. Once urine has passed through the external sphincter muscle, it can no longer be stopped.

Now, when specialized nerves in the bladder wall sense that the bladder is about half full, they send impulses to the spinal cord at levels S2 and S3, also known as the micturition center, and to the pons of the brain. The spinal cord response is part of the micturition reflex and it causes an increase in parasympathetic stimulation and decrease in sympathetic stimulation which makes the detrusor muscle contract and the internal sphincter relax.

It also decreases motor nerve stimulation to the external sphincter allowing it to relax as well. At this point, urination would occur, if not for the pons. The pons is the region that we train to voluntarily control urination. If we want to delay urination, the pons overrides the micturition reflex, and when we want to urinate, the pons allows for the micturition reflex to happen.

Now, there are several types of urinary incontinence. The first one is stress incontinence where urine leaks out when there’s a high abdominal pressure. Then there’s urgency incontinence where there’s a sudden urge to urinate. Then, there’s mixed incontinence which is a combination of stress and urgency incontinence. Finally, there’s overflow incontinence, when the bladder doesn’t empty completely. Now let’s look at them one by one.

Let’s start with stress incontinence which is due to increased abdominal pressure that overwhelms the sphincter muscles and allows urine to leak out. Some activities like sneezing, coughing or laughing increase abdominal pressure. This increases the pressure in the bladder and in turn, urine leaks out. If the pressure in the bladder is greater than the pressure in the sphincters, then the sphincters are unable to hold urine in.

For your tests, remember that if the sphincters are damaged, which is also called an outlet incompetence, then they can’t stop urine from leaking out. Now, outlet incompetence can be caused by urethral hypermobility or intrinsic sphincter deficiency. Now, urethral hypermobility is a condition where the urethra can’t be kept still by the muscles surrounding it because they are way too weak. One thing that can weaken the pelvic muscle is vaginal delivery. On the other hand, intrinsic sphincter deficiency is caused by damage to these sphincter muscles, which is often a complication of prostate surgery.

Okay, now, another risk factor for stress incontinence can be obesity because it increases the abdominal pressure and therefore, pressure in the bladder can sometimes be higher than the pressure of the sphincter. Similarly, pregnancy can also cause stress incontinence since the uterus rests above the bladder. The diagnosis can be made based on a positive bladder stress test where you can directly see urine leaking out when a person is coughing or does the Valsalva maneuver. This is when the clinician bears down and squeezes the abdominal muscles in order to increase abdominal pressure and cause urine to leak out. Stress incontinence treatments typically focus on strengthening the pelvic floor muscles by doing Kegel exercises. In individuals with obesity, weight loss is recommended and in females, using pessaries might be helpful.

Key Takeaways

Urinary incontinence is a common condition that occurs when urine involuntarily leaks from the bladder, often through the internal and external sphincter muscles. There are several types of urinary incontinence, including urge incontinence, stress incontinence, and overflow incontinence.

Urge incontinence is typically caused by an overactive bladder, which can lead to sudden and strong urges to urinate that are difficult to control. Stress incontinence, on the other hand, is often due to increased pressure on the bladder, which can happen during physical activity, sneezing, or coughing. Overflow incontinence is caused by incomplete emptying of the bladder, leading to urine leakage due to bladder overfilling.

The treatment for urinary incontinence depends on the underlying cause and severity of the condition. Some common interventions include strengthening the external sphincter muscle by doing things like Kegel exercises, and catheterization or medications like alpha-blockers, which relax the smooth muscle to assist with urination.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "First Aid for the USMLE Step 1 2018, 28th Edition" McGraw-Hill Education / Medical (2017)
  4. "Effectiveness of preoperative pelvic floor muscle training for urinary incontinence after radical prostatectomy: a meta-analysis" BMC Urology (2014)
  5. "Prevalence of postpartum urinary incontinence: a systematic review" Acta Obstetricia et Gynecologica Scandinavica (2010)
  6. "Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment" International Urogynecology Journal (2013)
  7. "Nonsurgical Management of Urinary Incontinence in Women: A Clinical Practice Guideline From the American College of Physicians" Annals of Internal Medicine (2014)
  8. "Benefits and Harms of Pharmacologic Treatment for Urinary Incontinence in Women" Annals of Internal Medicine (2012)